Episode
MS Drugs Stay on PBS Amid Price Pressure | Brisbane News
- Published
- Jul 16, 2026
- Duration seconds
- 142
- Processing state
not_requested- Canonical source
- https://sources.thednn.ai/f9df1f8fcc8f66f5
Actions
POST https://stenobird.com/v1/public/podcasts/brisbane-news-today-2-min-news-the-daily-news-now-7581033/episodes/ms-drugs-stay-on-pbs-amid-price-pressure-brisbane-news/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/brisbane-news-today-2-min-news-the-daily-news-now-7581033/ms-drugs-stay-on-pbs-amid-price-pressure-brisbane-news.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
The government has decided to keep key MS drugs on the PBS, ensuring patients continue to access them at low cost despite pressure from drugmakers threatening to pull them — a move that highlights the ongoing tug-of-war between affordability and innovation in Australia’s healthcare system. With a new cheaper MS drug on the market, manufacturers are being forced to accept lower prices, sparking backlash from companies claiming it undermines their R&D. Advocacy groups counter that these firms are among the world’s most profitable and that US pricing pressures shouldn’t dictate Australian costs. The PBAC is set to review usage by year’s end, as the government seeks to balance patient access with fiscal responsibility in a system where subsidies make life-saving treatments affordable — but not without tension. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/f9df1f8fcc8f66f5